5-carboxamidotryptamine has been researched along with corticosterone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frölich, D; Göthert, M; Likungu, J; Molderings, GJ | 1 |
| Duszynska, B; Hess, G; Pitra, P; Tokarski, K | 1 |
| Martínez-García, E; Sánchez-Maldonado, C; Terrón, JA | 1 |
3 other study(ies) available for 5-carboxamidotryptamine and corticosterone
| Article | Year |
|---|---|
Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cisapride; Corticosterone; Desipramine; Heart Atria; Humans; Indoles; Ketanserin; Male; Middle Aged; Norepinephrine; Oxadiazoles; Piperidines; Receptors, Presynaptic; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tritium; Tryptamines | 1996 |
Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT(7) receptors in rat hippocampus.
Topics: Animals; Antidepressive Agents, Tricyclic; Binding Sites; Corticosterone; Dose-Response Relationship, Drug; Drug Antagonism; Hippocampus; Imipramine; In Vitro Techniques; Male; Phenols; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides | 2009 |
5-HT7 receptor-mediated meningeal dilatation induced by 5-carboxamidotryptamine in rats is not altered by 5-HT depletion and chronic corticosterone treatment.
Topics: Animals; Brain; Corticosterone; Male; Meningeal Arteries; Oxadiazoles; Phenols; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Sulfonamides; Vasodilation | 2011 |